Polycystic Ovary Syndrome
Research Conducted at Mahidol University Has Provided New Information about Polycystic Ovary Syndrome
Published in Women's Health Weekly, October 27th, 2011
2011 OCT 27 -- In this recent article published in the Journal of Obstetrics and Gynaecology Research, scientists in Bangkok, Thailand conducted a study "To compare the efficacy of 1000 mg and 1700 mg of metformin on ovulation induction in polycystic ovary syndrome (PCOS) women. A randomized controlled trial was conducted at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand of 60 PCOS women diagnosed by Rotterdam criteria."
"Group A (30 women) and B (30 women) received 1000 mg and 1700 mg/day of metformin, respectively. Clomiphen citrate 50-150 mg per day for 5 days was added, if no dominant follicle developed. The main outcome measures...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Ovarian Cancer
Data on Ovarian Cancer Discussed by T. Yamano and Colleagues - Breast Cancer
Drug prevents bone loss side effects of breast cancer medication - Breast Cancer
Findings from I. Mittra and Co-Authors Provide New Insights into Breast Cancer - Ovarian Cancer
Findings from McGill University Provide New Insights into Ovarian Cancer - Breast Tumors
Hispanic women have higher incidence of rare breast tumor - Osteoporosis
Investigators at Health Center Target Osteoporosis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
